IVF (INVO Bioscience, Inc.) EV/EBITDA Multiple
INVO Fertility Inc (IVF) management is currently undergoing a structural reorganization following the merger of medical networks, awaiting shareholder recognition of the resulting synergies. High barriers to entry are maintained by patents and strict ethical standards within the reproductive sector. This historical price chart on GURU.Markets shows an EV/EBITDA of 0.00, illustrating the valuation of a business creating the INVOcell system for in vivo fertilization, which significantly reduces IVF costs.
Summary analytical data breakdowns for invobioscience.com (IVF)
- stock price and consensus target price:
- business market valuation indicators:
- issuer book value statistics:
- debt and liquidity data:
- financial results and valuation multiples details:
IVF - Net Income|Projected Future Earnings INVO Fertility Inc|IVF - P/E Multiple|Future Price to Earnings INVO Fertility Inc|IVF - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio INVO Fertility Corp|IVF - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) INVO Fertility|IVF - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months invobioscience.com|IVF - Net earnings per share change in current year|Expected earnings per share growth for next year INVO Fertility Inc
Initial company analysis:INVO Bioscience, Inc. IVF
INVO Fertility Inc (IVF) maintains a unique niche in reproductive medicine through the implementation of the intrauterine embryo incubation method. The EV/EBITDA multiple quantifies the value of this technological advantage by comparing the total enterprise value, including debt and taxes, with its operating profit. Analyzing the historical EV/EBITDA trend of INVO Fertility Inc (IVF) allows for an assessment of the efficiency of its capital-intensive model and determines the fairness of the asset's market value.
Competitor analysis for INVO Fertility Inc
Boston Scientific Inc - Enterprise Value to EBITDA Ratio|EW (Edwards Lifesciences Inc.) - Company Value to Operating Income Before Depreciation Ratio|ResMed Inc. - EV/EBITDA Multiple|Company Value to EBITDA insulet.com|ZBH: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation COO|Enterprise Value to EBITDA Ratio ALGN|GMED: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TransMedics (TMDX)|Enterprise Value to EBITDA Ratio atecspine.com ATEC|EV/EBITDA Multiple AORT (Artivion)|Enovis Corp (ENOV) - Company Value to EBITDA|Integra - EV/EBITDA Multiple|ESTA (Establishment Labs Inc) - Enterprise Value to Operating Income Before Depreciation|BBNX: EV/EBITDA Multiple|IRMD - Total Company Value to Operating Income Before Depreciation Ratio|EMBC (Embecta) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Tandem Diabetes Care Inc (TNDM)|EV/EBITDA Multiple AXGN|EV/EBITDA Multiple SI-BONE Medical (SIBN)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Orthofix Medical Inc. OFIX|bioventus.com - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|KIDS: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation TMCI (Treace Medical Concepts Inc)|SRTA: EV/EBITDA Multiple|Company Value to EBITDA Carlsmed Medical (CARL)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization RxSight, Inc.|CLPT - Enterprise Value to EBITDA Multiple|Enterprise Value to EBITDA Ratio STXS (Stereotaxis)|EV/EBITDA Multiple Neuronetics Inc. (STIM)|EV/EBITDA Multiple SGHT (Sight Sciences, Inc)|Total Company Value to Operating Income Before Depreciation Ratio orchestrabiomed.com (OBIO)|ANIK - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio NSPR|zhjmedical.com (ZJYL) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Vivani Medical|XTNT (Xtant Medical Holdings, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA NeuroOne Medical Technologies Corp. NMTC|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Modular Medical (MODD)|myomo.com - Enterprise Value to Operating Income Before Depreciation|Envoy Medical - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio VVOS (Vivos Therapeutics Inc.)|enVVeno - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Sintx Technologies SINT|Tenon Medical, Inc. (TNON) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation LFWD|Enterprise Value to EBITDA Ratio AMIX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BBLG|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Axonics Modulation Technologies (AXNX)|BIOL - Company Value to EBITDA|Dynatronics - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation FNA|INVO Bio - EV/EBITDA Multiple
